Sharma East India Hospitals & Medical Research Ltd Stock Price Today (NSE: SHARMEH)
Sharma East India Hospitals & Medical Research Ltd
Fundamental Score
Sharma East India Hospitals & Medical Research Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sharma East India Hospitals & Medical Research Ltd share price today is ₹90.79, down 3.41% on NSE/BSE as of 22 September 2026. Sharma East India Hospitals & Medical Research Ltd (SHARMEH) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹29.81 (Cr). The 52-week high for SHARMEH share price is ₹176.55 and the 52-week low is ₹80.15. At a P/E ratio of 25.22x, SHARMEH is currently trading below its industry average P/E of 42.23x. The company has a Return on Equity (ROE) of 9.47% and a debt-to-equity ratio of 0.53.
Sharma East India Hospitals & Medical Research Ltd Share Price Chart — NSE/BSE Historical Performance
Sharma East India Hospitals & Medical Research Ltd share price chart: -5.18% return over the past month. 52-week high ₹176.55, 52-week low ₹80.15.
Sharma East India Hospitals & Medical Research Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹95.50 | ₹95.50 | ₹89.66 | ₹89.70 | 526.00 (Cr) | |
| ₹95.00 | ₹98.50 | ₹88.00 | ₹92.00 | 266.00 (Cr) | |
| ₹89.00 | ₹90.00 | ₹87.00 | ₹87.01 | 496.00 (Cr) | |
| ₹99.00 | ₹99.00 | ₹90.10 | ₹90.20 | 5.00 (Cr) | |
| ₹95.99 | ₹95.99 | ₹90.15 | ₹92.25 | 434.00 (Cr) | |
| ₹93.50 | ₹93.50 | ₹89.00 | ₹90.42 | 316.00 (Cr) | |
| ₹99.00 | ₹100.00 | ₹91.00 | ₹93.50 | 148.00 (Cr) | |
| ₹95.00 | ₹95.00 | ₹89.50 | ₹90.00 | 62.00 (Cr) | |
| ₹94.07 | ₹99.90 | ₹92.00 | ₹94.05 | 871.00 (Cr) | |
| ₹98.99 | ₹98.99 | ₹93.25 | ₹96.00 | 134.00 (Cr) |
Sharma East India Hospitals & Medical Research Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹96.14 | ₹100.00 | ₹87.00 | ₹89.70 | -6.70% | |
| ₹100.90 | ₹105.95 | ₹89.35 | ₹96.90 | -3.96% | |
| ₹115.00 | ₹115.00 | ₹91.00 | ₹99.75 | -13.26% | |
| ₹101.20 | ₹119.70 | ₹95.10 | ₹97.70 | -3.46% | |
| ₹97.00 | ₹124.62 | ₹85.00 | ₹108.18 | +11.53% | |
| ₹106.95 | ₹114.00 | ₹85.60 | ₹95.85 | -10.38% | |
| ₹97.00 | ₹111.99 | ₹80.15 | ₹103.48 | +6.68% | |
| ₹111.00 | ₹129.90 | ₹86.70 | ₹98.85 | -10.95% | |
| ₹129.40 | ₹134.00 | ₹92.35 | ₹105.65 | -18.35% | |
| ₹139.55 | ₹150.50 | ₹118.25 | ₹130.70 | -6.34% | |
| ₹135.50 | ₹142.05 | ₹120.90 | ₹132.95 | -1.88% | |
| ₹153.45 | ₹172.90 | ₹134.70 | ₹138.25 | -9.91% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Sharma East India Hospitals & Medical Research Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sharma East India Hospitals & Medical Research Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SHARMEH across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Attractive Valuation (P/E: 25.22 vs Industry: 42.23)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (34.61% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (21.39% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (53.63%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Below-Average Return on Equity (9.47%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Profit Decline Concern (-18.24%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Sharma East India Hospitals & Medical Research Ltd vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Sharma East India Hospitals & Medical Research Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
55.5/100 | ₹90.79₹91 | ₹29.81₹29.81 | 25.22Average 25.2 Average | 9.47%Poor 9.47% Poor | 14.60%Average 14.60% Average | 0.53Good 0.5 Good | 21.39%Excellent 21.39% Excellent | 34.61%Excellent 34.61% Excellent | 0.00% | |
Dr. Lal Path Labs Ltd.Dr. Lal Path La... LALPATHLAB • 539524 | 57.7/100 | ₹1919.70₹1920 | ₹32174.17₹32174.17 | 46.28Average 46.3 Average | 21.57%Excellent 21.57% Excellent | 27.62%Excellent 27.62% Excellent | 0.00Excellent 0.0 Excellent | 11.60%Good 11.60% Good | 11.81%Good 11.81% Good | 0.81% |
Vijaya Diagnostic Centre LimitedVijaya Diagnost... VIJAYA • 543350 | 67.8/100 | ₹1498.90₹1499 | ₹15423.23₹15423.23 | 82.22Average 82.2 Average | 19.74%Good 19.74% Good | 21.32%Excellent 21.32% Excellent | 0.00Excellent 0.0 Excellent | 15.47%Excellent 15.47% Excellent | 16.66%Excellent 16.66% Excellent | 0.14% |
Metropolis Healthcare LimitedMetropolis Heal... METROPOLIS • 542650 | 57.9/100 | ₹602.10₹602 | ₹12483.64₹12483.64 | 25.79Average 25.8 Average | 13.36%Average 13.36% Average | 16.80%Good 16.80% Good | 0.01Excellent 0.0 Excellent | 0.74%Average 0.74% Average | 10.52%Good 10.52% Good | 0.35% |
Thyrocare Technologies LimitedThyrocare Techn... THYROCARE • 539871 | 46.7/100 | ₹566.85₹567 | ₹9022.55₹9022.55 | 33.17Average 33.2 Average | 28.80%Excellent 28.80% Excellent | 35.47%Excellent 35.47% Excellent | 0.00Excellent 0.0 Excellent | 8.37%Good 8.37% Good | 10.88%Good 10.88% Good | 1.76% |
Krsnaa Diagnostics LimitedKrsnaa Diagnost... KRSNAA • 543328 | 31.9/100 | ₹560.95₹561 | ₹1819.61₹1819.61 | 18.66Average 18.7 Average | 10.89%Average 10.89% Average | 13.05%Average 13.05% Average | 0.55Good 0.5 Good | -11.13%Poor -11.13% Poor | 11.75%Good 11.75% Good | 0.50% |
Suraksha Diagnostic LimitedSuraksha Diagno... SURAKSHA • 544293 | 56.2/100 | ₹335.65₹336 | ₹1748.10₹1748.10 | 48.79Average 48.8 Average | 14.11%Average 14.11% Average | 16.82%Good 16.82% Good | 0.01Excellent 0.0 Excellent | 31.68%Excellent 31.68% Excellent | 17.26%Excellent 17.26% Excellent | 0.00% |
One Global Service Provider LimitedOne Global Serv... ONEGLOBAL • 514330 | 82.2/100 | ₹540.40₹540 | ₹1178.25₹1178.25 | 16.95Average 16.9 Average | 65.27%Excellent 65.27% Excellent | 87.02%Excellent 87.02% Excellent | 0.00Excellent 0.0 Excellent | 97.21%Excellent 97.21% Excellent | 167.02%Excellent 167.02% Excellent | 0.00% |
3B Blackbio Dx Limited3B Blackbio Dx ... 3BBLACKBIO • 532067 | 60.3/100 | ₹1476.10₹1476 | ₹1079.13₹1079.13 | 18.42Average 18.4 Average | 19.77%Good 19.77% Good | 25.48%Excellent 25.48% Excellent | 0.01Excellent 0.0 Excellent | -12.44%Poor -12.44% Poor | -8.95%Poor -8.95% Poor | 0.31% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 39/100 | ₹301.45₹301 | ₹1035.54₹1035.54 | 539.34Average 539.3 Average | 0.29%Poor 0.29% Poor | -0.05%Poor -0.05% Poor | 0.04Excellent 0.0 Excellent | 16.91%Excellent 16.91% Excellent | 19.09%Excellent 19.09% Excellent | 0.00% |
49.4/100 | ₹209.20₹209 | ₹600.78₹600.78 | 20.55Average 20.6 Average | 19.92%Good 19.92% Good | 23.27%Excellent 23.27% Excellent | 0.31Excellent 0.3 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr. Lal Path Labs Ltd. share price32174.17 Cr
- Vijaya Diagnostic Centre Limited share price15423.23 Cr
- Metropolis Healthcare Limited share price12483.64 Cr
- Thyrocare Technologies Limited share price9022.55 Cr
- Krsnaa Diagnostics Limited share price1819.61 Cr
Sharma East India Hospitals & Medical Research Ltd Quarterly Performance
Latest quarterly metrics for SHARMEH — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
13.68%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-18.24%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
34.61%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
21.39%
Compounded annual net profit growth over 5 years
Sharma East India Hospitals & Medical Research Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SHARMEH — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Sharma East India Hospitals & Medical Research Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Sharma East India Hospitals & Medical Research Ltd (SHARMEH) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Sharma East India Hospitals & Medical Research Ltd
About SHARMEH (Sharma East India Hospitals & Medical Research Ltd)
Sharma East India Hospitals & Medical Research Ltd is a pioneering healthcare institution deeply rooted in the vibrant landscape of Jaipur, India. Since its inception in 1989, the ...organization has diligently cultivated a reputation for delivering comprehensive and compassionate medical care to the communities it serves. Operating under the esteemed banner of Jaipur Hospital, SHARMEH has steadily evolved into a trusted name synonymous with quality and accessibility in the East Indian healthcare sector. More than just a facility, SHARMEH stands as a beacon of hope, embracing a patient-centric approach that prioritizes individual well-being and strives to create a healing environment. SHARMEH embodies a multi-specialty approach, integrating a wide spectrum of medical disciplines to cater to the diverse needs of its patients. From advanced diagnostic procedures and cutting-edge surgical interventions to specialized rehabilitation therapies and personalized wellness programs, SHARMEH offers a holistic continuum of care under one roof. The organization's commitment to innovation is evident in its continuous investment in state-of-the-art technology and the cultivation of a highly skilled medical team composed of experienced physicians, nurses, and allied healthcare professionals. The hospital's unwavering dedication to excellence ensures that patients receive the most effective and contemporary treatments available. SHARMEH's influence extends far beyond the confines of its physical location, contributing significantly to the advancement of medical research and education within the region. Through its active engagement in clinical trials and collaborative research initiatives, the hospital plays a crucial role in shaping the future of healthcare practices. Moreover, SHARMEH is dedicated to fostering a culture of continuous learning, providing training opportunities for aspiring medical professionals and empowering its staff to stay at the forefront of medical breakthroughs. Ultimately, Sharma East India Hospitals & Medical Research Ltd aims to be a catalyst for positive change, elevating healthcare standards and improving the lives of individuals across East India.
Company Details
Key Leadership
SHARMEH Share Price: Frequently Asked Questions
What is the current share price of Sharma East India Hospitals & Medical Research Ltd?
Sharma East India Hospitals & Medical Research Ltd (SHARMEH) trades at ₹90.79 on NSE and BSE. Market cap ₹29.81 (Cr). Educational data only.
What is the P/E ratio of Sharma East India Hospitals & Medical Research Ltd?
Sharma East India Hospitals & Medical Research Ltd has a P/E of 25.22x vs industry average 42.23x.
What is the Bull Run score for Sharma East India Hospitals & Medical Research Ltd?
Sharma East India Hospitals & Medical Research Ltd has a Bull Run score of 55.5/100 based on 25+ financial parameters.
Does Sharma East India Hospitals & Medical Research Ltd pay dividends?
Sharma East India Hospitals & Medical Research Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Sharma East India Hospitals & Medical Research Ltd?
Sharma East India Hospitals & Medical Research Ltd has ROE of 9.47%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Sharma East India Hospitals & Medical Research Ltd?
Sharma East India Hospitals & Medical Research Ltd has debt-to-equity of 0.53.
Is Sharma East India Hospitals & Medical Research Ltd a good investment?
Bull Run gives Sharma East India Hospitals & Medical Research Ltd a score of 55.5/100. This is not investment advice — consult a SEBI-registered advisor.